Skip to main content

Myocardial contractility after in Vitro treatment with class III antiarrhythmic drug Nibentan

Abstract

Myocardial contractility was studied in vitro in response to treatment with class III antiarrhythmic drug Nibentan. The contractile response to Nibentan in increasing concentrations of 1.66, 2.5, and 3.5 mM was estimated on strips of animal myocardium and human right atrial auricle.

This is a preview of subscription content, access via your institution.

References

  1. K. Yu. Bogdanov, T. M. Vinogradova, and L. V. Rozenshtraukh, Kardiologiya, 37, No. 4, 28–33 (1997).

    Google Scholar 

  2. L. V. Rozenshtraukh, E. P. Anyukhovskii, G. G. Beloshapko, et al., Ibid., 35, No. 5, 25–36 (1995).

    Google Scholar 

  3. V. V. Fedorov, O. F. Sharifov, L. V. Rozenshtraukh, et al., Ibid., 39, No. 3, 45–57 (1999).

    Google Scholar 

  4. V. V. Fedorov, O. F. Sharifov, L. V. Rozenshtraukh, et al., Ibid., 40, No. 2, 37–47 (2000).

    Google Scholar 

  5. P. Dorian, J. Cardiovasc. Pharmacol. Ther., 8,Suppl. 1, S27–S31 (2003).

    CAS  PubMed  Google Scholar 

  6. S. Nattel, T. Hadjis, and M. Talajic, Drugs, 48, 345–371 (1994).

    CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to R. F. Gaifullina.

Additional information

__________

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 141, No. 1, pp. 89–91, January, 2006

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Latfullin, I.A., Gaifullina, R.F., Dzhordzhikiya, R.K. et al. Myocardial contractility after in Vitro treatment with class III antiarrhythmic drug Nibentan. Bull Exp Biol Med 141, 81–83 (2006). https://doi.org/10.1007/s10517-006-0099-y

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-006-0099-y

Key Words

  • Nibentan
  • myocardial contractility